Transmittals and MLN Matters articles: CMS issues NCD for prostate cancer treatment, updates ESRD PPS, and more
Medicare Weekly Update, July 19, 2011
Want to receive articles like this one in your inbox? Subscribe to Medicare Weekly Update!
CMS makes quarterly update to ESRD PPS
On July 15, CMS issued a transmittal to make quarterly updates to the end-stage renal disease prospective payment system (ESRD PPS).
Effective date: The effective date for the ICD-9-CM updates is October 1, 2011; the effective date for the DME list corrections is January 1, 2011
Implementation date: October 3, 2011
CMS posts NCD for autologous cellular immunotherapy treatment of metastatic prostate cancer
On July 8, CMS issued two transmittals related to coverage of autologous cellular immunotherapy treatment - sipuleucel-T; PROVENGE®. CMS has concluded that sipuleucel-T improves health outcomes for Medicare beneficiaries with asymptomatic or minimally symptomatic metastatic castrate-resistant (hormone refractory) prostate cancer, and thus is reasonable and necessary for this on-label indication.
Effective date: June 30, 2011
Implementation date: August 8, 2011 and January 3, 2012 (CWF frequency edit only)
View the National Coverage Determination Manual transmittal.
View the Claims Processing Manual transmittal.
CMS revises flu vaccine instructions
On July 8, CMS issued two transmittals to make changes to the Claims Processing Manual and the Benefit Policy Manual regarding the timing of the influenza vaccine.
Effective date: August 8, 2011
Implementation date: August 8, 2011
View the Claims Processing Manual transmittal.
View the Benefit Policy Manual transmittal.
CMS replaces transmittal
CMS rescinded and replaced a transmittal previously outlined in Medicare Weekly Update.
Want to receive articles like this one in your inbox? Subscribe to Medicare Weekly Update!
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: Level of encryption needed for email
- Catch up on what's new with injections and infusions
- Identify potential Medicaid RAC target areas
- Topic: CMS, OESS post new security compliance review information, checklist
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- Q/A: Coding infusions to correct low potassium levels
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: Level of encryption needed for email
- CMS has reformulated payments for some bilateral procedures
- Q&A: Follow CMS' coding guidelines when using modifier -25
- Understand the spine to code back procedures correctly
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- Searched
